Medium vs Low Oxygen Threshold for the Surfactant Administration
NCT04199364
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Respiratory Distress Syndrome
Interventions
DRUG:
Poractant Alfa 80 mg/mL Intratracheal Suspension
Sponsor
Virgilio Paolo Carnielli